🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Ilinois › Springfield

Kliničke studije za Немалоклетни карцином плућа u gradu Springfield, IL

14 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Springfield i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Тражи се учесникФаза 3
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07388524

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Springfield Clinic Main Campus, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Тражи се учесникОпсервациона студија
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Springfield Clinic Main Campus, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Тражи се учесникФаза 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT03191149

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Тражи се учесникФаза 3
  • Springfield Clinic Main Campus, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06875310

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • Springfield Clinic - First /ID# 272576, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06568939

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07393555

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Southern Illinois University - Simmons Cancer Institute, Springfield
  • Springfield Clinic Radiology - 800 Building, Springfield
  • Springfield Clinic Urgent Care Plus, Springfield
  • и још 4
Узраст 18 и старији · Оба пола · Ажурирано 6. 7. 2026. · NCT04389632

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Springfield

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.